NxStage Medical Earnings Preview: Get Ahead of the Analysts

NxStage Medical (NASDAQ:NXTM) will report earnings before markets open on Thursday, May 2nd. NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company’s primary product, the NxStage System One, is a small, portable hemodialysis system.

Here is your Cheat Sheet to Nxstage Medical Earnings:

Earnings Expectations: Analysts expect earnings of $-0.08 per share on revenues of $61.14 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.03 to a loss $0.07. For the current year, the average estimate is a loss of $0.24, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Nxstage Medical has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 128.76 148.68 179.22 217.26 242.13
Diluted EPS ($) -1.23 -0.93 -0.66 -0.39 -0.26

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 57.02 56.95 59.01 61.15 65.02
Diluted EPS ($) -0.0830 -0.09 -0.09 -0.04 -0.0400

Past Performance:
Nxstage Medical has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)